185 related articles for article (PubMed ID: 28685817)
21. The efficiency of progesterone/estradiol and progesterone/follicle ratio without elevated trigger-day progesterone levels on the reproductive outcomes of GnRH antagonist IVF/ICSI cycles.
Tokgoz VY; Ekici GC; Tekin AB
Gynecol Endocrinol; 2021 Oct; 37(10):885-890. PubMed ID: 33517800
[TBL] [Abstract][Full Text] [Related]
22. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
23. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
[TBL] [Abstract][Full Text] [Related]
24. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
[TBL] [Abstract][Full Text] [Related]
25. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
[TBL] [Abstract][Full Text] [Related]
26. Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos.
Polotsky AJ; Daif JL; Jindal S; Lieman HJ; Santoro N; Pal L
Fertil Steril; 2009 Dec; 92(6):1880-5. PubMed ID: 18851847
[TBL] [Abstract][Full Text] [Related]
27. Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?
Hill MJ; Royster GD; Healy MW; Richter KS; Levy G; DeCherney AH; Levens ED; Suthar G; Widra E; Levy MJ
Fertil Steril; 2015 Jun; 103(6):1477-84.e1-5. PubMed ID: 25881880
[TBL] [Abstract][Full Text] [Related]
28. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
30. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
[TBL] [Abstract][Full Text] [Related]
31. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
Ren J; Sha A; Han D; Li P; Geng J; Ma C
Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
[TBL] [Abstract][Full Text] [Related]
32. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?
Azem F; Tal G; Lessing JB; Malcov M; Ben-Yosef D; Almog B; Amit A
Gynecol Endocrinol; 2008 Jul; 24(7):368-72. PubMed ID: 18645708
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
34. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law.
Corti L; Papaleo E; Pagliardini L; Rabellotti E; Molgora M; La Marca A; Vigano P; Candiani M
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):73-7. PubMed ID: 24012449
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates.
Santos-Ribeiro S; Racca A; Roelens C; De Munck N; Mackens S; Drakopoulos P; Tournaye H; Blockeel C
Reprod Biomed Online; 2019 Apr; 38(4):647-654. PubMed ID: 30593439
[TBL] [Abstract][Full Text] [Related]
36. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
37. Elevated progesterone and its impact on birth weight after fresh embryo transfers.
Ibrahim Y; Haviland MJ; Hacker MR; Penzias AS; Thornton KL; Sakkas D
J Assist Reprod Genet; 2017 Jun; 34(6):759-764. PubMed ID: 28417348
[TBL] [Abstract][Full Text] [Related]
38. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
39. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
40. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
Papaleo E; Corti L; Vanni VS; Pagliardini L; Ottolina J; De Michele F; La Marca A; Viganò P; Candiani M
Arch Gynecol Obstet; 2014 Jul; 290(1):169-76. PubMed ID: 24549270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
